China Nepstar Chain Drugstore, the largest retail drugstore chain in China, filed terms with the SEC Friday for its upcoming IPO. The company plans to offer 20.6 million ADRs at a price range of $11.50 to $13.50 per ADR. Goldman Sachs is the lead manager on the deal.
